Genu Recurvatum Market Share, Trends, Growth Rate, Industry Report And Forecast To 2033

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Genu Recurvatum Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The genu recurvatum market size has grown strongly in recent years. It will grow from $7.12 billion in 2023 to $7.57 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to orthopedic conditions prevalence, aging population, trauma and accidents, limited awareness and early diagnosis.

The genu recurvatum market size is expected to see strong growth in the next few years. It will grow to $9.71 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising awareness and education, advancements in treatment options, sports injury prevention and management, rehabilitation programs. Major trends in the forecast period include integration of digital health technologies, collaboration between orthopedic specialists and physical therapists, research on biomechanics and musculoskeletal health, focus on pediatric and adolescent cases, rehabilitation and strength training emphasis.

Get Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12425&type=smp

Market Segmentation:
The genu recurvatum market covered in this report is segmented -

1) By Type: External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)
2) By Diagnosis: Magnetic Resonance Imaging (MRI), X-Rays, Other Diagnosis
3) By Treatment: Physical Therapy, Orthoses, Bracing, Surgery
4) By End-Users: Hospital, Clinics, Other End-Users

Major Driver - The Surge In Genu Recurvatum Market Driven By Orthopedic Cases
The increasing prevalence of orthopedic disorders is expected to propel the growth of the genu recurvatum market going forward. Orthopedic disorders refer to conditions that affect the musculoskeletal system, including the bones, joints, muscles, tendons, ligaments, and cartilage. Genu recurvatum causes knee pain and leads to knee osteoarthritis and other orthopedic disorders. The increasing cases of orthopedic conditions will demand treatment, which will support the market's growth. For instance, in February 2022, according to the Office of Disease Prevention and Health Promotion, a US-based government health agency, it is anticipated that in 2040 78.4 million adults will have arthritis. Over 52.5 million adult Americans, or more than 22% of the population, have arthritis. Furthermore, in 2021, according to Versus Arthritis, a UK-based charity dedicated to people with arthritis, in 2022, there were 20,295,706 people with musculoskeletal conditions in the UK and for MSK disorders and joint problems. Therefore, the increasing prevalence of orthopedic disorders is driving the growth of the genu recurvatum market.

Competitive Landscape:
Major companies operating in the genu recurvatum market report are Medtronic plc, Johnson & Johnson MedTech,Stryker Corporation, DePuy Synthes Inc., Zimmer Inc., Smith & Nephew plc, Arthrex, NuVasive Inc., DJO Global Inc., Globus Medical Inc., Össur hf, AliMed Inc., Thuasne Ltd., Orthofix Inc, Prim SA, OrthoPro Inc., Performance Health, Trulife Group Limited, Breg Inc., Allard USA, Capstone Orthopedic Inc., Twin Cities Orthopedics, ReWalk Robotics, BraceAbility, KevinRoot Medical.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/genu-recurvatum-global-market-report

Top Trend - Technological Trends Reshaping The Genu Recurvatum Market
Technological advancements are a key trend gaining popularity in the genu recurvatum market. Major companies operating in the genu recurvatum market are developing technologically advanced products to sustain their position in the market. For instance, in November 2022, Ortho Development Corporation, a US-based orthopedic device design and manufacturing company, launched BKS Total PSI in collaboration with Materialize NV, a Belgium-based company in 3D printing / additive manufacturing. BKS Total PSI, driven by Materialize, improves total knee arthroplasty predictability and control by providing patient-specific virtual visualization, preoperative planning, and precise 3D-printed guidance.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Genu Recurvatum Market Characteristics
3. Genu Recurvatum Market Trends And Strategies
4. Genu Recurvatum Market - Macro Economic Scenario
5. Genu Recurvatum Market Size And Growth
…..
27. Genu Recurvatum Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.